In addition, in SSc patients the serum CCL18 concentration is a meaningful predictor of mortality and progression of ILD [154,156], and the level of CCL18 produced by BAL cells and in serum reflects the fibrotic activity seen in SSc-ILD [151]. Here, CCL18 is linked to systemic sclerosis.